Bottom Swing Plays Chat

[gdog]

yea I don't get into them that much I find a low where i think they will reverse buy there for 3-10% gain and sell. I hardly ever know what they are or do.

[surfer44]

Thx. What's really cool is their website which shows the floorplans, pictures of interiors, prices and locations of China's apartments, etc. Like Zillow.

[gdog]

nice

[surfer44]

I've had it a while.

[gdog]

yea I/m banking on it bought it 2 days ago

[surfer44]

I just joined Bottom Fish Stocks. Figure I'd change it up. It's lonely where I reside

[surfer44]

OPI looks interesting too.

[surfer44]

BEKE might catch a bid. China's real estate sector got obliterated and might be in recovery.

[surfer44]

On FED watch...

[surfer44]

LOL

[gdog]

thxs all we do is win on Bottom swing trade thread.....

[surfer44]

I have longer term investments that I trade around. RIG might be getting a nibble.

[surfer44]

Hello BSPC! I just gave this board a follow. GLTA

[ProfitScout]

$CYCA News: Cytta Corp Revolutionizes Public Safety With Four New Florida CyttaCOMMS Deployments In One Week

CyttaCOMMS In Active Trials With 54 Florida Law Enforcement Agencies With Over 600 Florida Direct Demo Requests Outstanding

LAS VEGAS, NV / ACCESSWIRE / July 26, 2024 / Cytta Corp (OTCQB:CYCA), the frontrunner in real-time video streaming technology and incident command software for public safety, is thrilled to announce the dynamic deployment of CyttaCOMMS 3.0 to four new law enforcement agencies in Florida: Temple Terrace PD, Plant City PD, Lake Placid PD, and Port St. Lucie PD last week.

Nationwide Expansion and Surging Interest

The buzz around CyttaCOMMS is undeniable, with free trials now active in 54 Florida law enforcement agencies and over 600 direct demo requests from Florida alone. This wave of interest highlights the pivotal role of CyttaCOMMS in revolutionizing public safety through state-of-the-art drone streaming technology.

This cutting-edge deployment is set to redefine public safety operations with secure, real-time video streaming and incident command features that significantly enhance drone capabilities. Our seamless integration across all drone brands is essential in the wake of Florida's statewide ban on DJI drones, ensuring these agencies remain at the forefront of technological advancement.

Unmatched Secure and Efficient Operations

CyttaCOMMS 3.0 provides unparalleled secure, low-latency video streaming, vital for real-time situational awareness. This transformative technology enhances coordination, response times, and operational efficiency during critical incidents.

Exciting Growth in CyttaAIR and CyttaCARES Initiatives

Our CyttaAIR program is soaring, with a second reselling group now established in Texas, showcasing our dedication to pioneering drone solutions. Moreover, our CyttaCARES initiative continues to be a cornerstone of our mission, focusing on community support and technological empowerment to boost safety and well-being.

About Cytta Corp

Cytta Corp (OTCQB:CYCA) is at the cutting edge of video streaming and communication solutions, driving innovation to enhance operational efficiency and public safety. Our flagship product, CyttaCOMMS, ensures secure, real-time video streaming across any drone brand, providing seamless integration and heightened situational awareness for law enforcement and emergency responders. Cytta's innovative new product, CyttaCARES , is a game-changer in ensuring the safety and well-being of children in educational institutions and beyond. CyttaAIR, a groundbreaking platform designed to innovate and consolidate the best of drone hardware, software, and resources for Federal and State Law Enforcement Agencies. Cytta's CyttaCOMP ISTAR (Intelligence, Surveillance, Target Acquisition and Reconnaissance) technology delivers real-time compression of video streams with ultra-low latency.

For more information about Cytta Corp and our groundbreaking technology solutions, please visit www.cytta.com.

Contact Us

Cytta Corp.
Toll free # : 1 877 CYTTAUS (298 8287)
Call Local : 1 740 CYTTAUS (298 8287)
http://www.cytta.com
[e-mail]

Gary Campbell, CEO
Direct [phone] (or message)
[e-mail]

Natalia Sokolova, President & COO
Direct: [phone] (or message)
[e-mail]

Mike Elliott, VP of Business Development
[e-mail]
[phone].

SOURCE: Cytta Corp.

[gdog]

They always do.

[Boxsterfan]

Yep some. Now watch the stock skyrocket.

[gdog]

hopefully u made $$$$

[Boxsterfan]

Sold all SLS. CEO lied and said no dilution until after Interim Analysis which was to be by end of Q3.

When the CEO lies, you move on.

[gdog]

nice gains from the 1.10 mention🤩

[Boxsterfan]

Yes, I'm liking my 200,000 shares long. Binary event is approaching for them.

1. Will their REGAL trial halt for efficacy at 60 events (deaths) Interim Analysis with a hazard ratio of 0.52? Essentially, is the median overall survival (MOS) of their drug extend by double (Ex: 24 months vs 12 months)? If it halts, it is headed to $15 straight away. Currently, no futility or safety concerns with drug reported since the trial started 3 years ago so that is essentially off the table.

2. If they don't get halt for efficacy at 60 events for Interim Analysis, the trial will continue to conclusion at 80 events (deaths) which will likely take the trial until Q1 2025. The need a hazard ratio of 0.62 at Final Analysis to have immediately successful trial results. There are cases were a hazard ratio slightly above that number could still gain approval because the secondary endpoints on toxicity are likely to be met. In short, current best available treatments come with lots of side effects.

3. Shorts will cut the stock to $0.80/share if 60 events does not get halt for efficacy because the company will need to dilute. The only thing that stops dilution before REGAL trial completes (if it has to go to 80 events) would be settlement with 3DMedical which owes them at least $13M minimum or their other drug SLS009 (Phase 2 AML patients with ASX1 mutation showing 100% response rate) gets a partnership deal.

Place your bets.

[manfromjax]

Looks like SLS is moving up. I'm glad I added another 100 at 1.20 yesterday.

[gdog]

thx u I'm sure we will

[manfromjax]

I was there some 50 years ago when I lived in the Rockville MD area. Nice big park with lots of battle sites. I imagine it has been improved since then. Have fun.

[gdog]

well you'll get a kick out of this but when I was 9-10 yrs old I played civil war with a friend ( Manual Gentile) 4 yrs ago a different friend of mine told me he was a guide there so I hope to see him. he was a nut about the civil war had all kinds of outfits, pretend guns lol anyhow I hope to see him as he moved away after high school and I havn't seen or heard from him since. I'm 71 yrs old now so its been awhile. will check the rds thxs for the heads up.

[Boxsterfan]

The park's website says there are some road closures.

https://www.nps.gov/gett/planyourvisit/conditions.htm

Check yourself for ticks.

But as far as a destination, looks interesting especially if you are interested in history.

[gdog]

I'm heading to PA to the Gettysburg National Military Park Sunday the 2nd anyone been there and have any advise ?????????

[gdog]

totally agree.

[Boxsterfan]

No idea. The bottom swing on ALLR was at $0.14 to $0.15/share. Now that it is up 50% from that bottom, it is time to move on. It's not going anywhere. There are many many many many other opportunities in the market. Even daily swing trades on blue chips are a better option.

[Lvogel]

Anybody know what caused the small jump in ALLR today? Is it expected to continue next week is it just a pump that will go down on Monday?

[gdog]

No taking a break from IHUB . gl My friend.

[Boxsterfan]

So you are no longer checking here?

[Boxsterfan]

If I am going to retire early, it will be because of SLS. If not, I will end up working for another 20 years.

[manfromjax]

Guess I should thank you for SLS. I took a 500 shares position at 1.10 last week. It is about the only stock I own that has kept it gain since buying in this crappy market. Sure better than ALLR.

[gdog]

My flip on MBLY has turned in to a play lol

[gdog]

nice jop flipping so many i lost track of SLS

[Boxsterfan]

SLS up approximately 12% since July 18th. $1.10 ----> $1.25

Still holding.

[gdog]

yea not sure what to expect with sec mess.

[manfromjax]

WOW, am I going to be happy that I picked up 2000 more shares of ALLR at .17!!!
average is now .32.
Was up to .30 as I sit here in Riga Latvia.

[gdog]

well I probably would have sold before 10.45 anyhow but sure wished I wouldn't have sold at 3.80 lol

[Boxsterfan]

Looks like NAAS trade halted earlier today. Now at $7.33. Seems like you lucked out?

[gdog]

what a huge mistake just touched $10.00
NAAS

[gdog]

could be enjoy over there.

[manfromjax]

What is happening back there in America. Why is the market falling? Poland and these Baltic countries are booming. Wonder if all that USA money Biden is sending over here is going into the right pockets

[ProfitScout]

$IVDN (16 million float) is about to file a banner quarterly report for its fiscal Q2 which will show that sales of its superior Insultex House Wrap product have already exceeded all of the company's results for the full 2023 fiscal year.

This has been pre-announced in the last two IVDN news releases:

Innovative Designs Sales Update
May 30, 2024
https://finance.yahoo.com/news/innovative-designs-sales-110000236.html

Innovative Designs Vendor Growth
April 10, 2024
https://finance.yahoo.com/news/innovative-designs-vendor-growth-174255528.html

[gdog]

NAAS hits $7.14 hod man did I sell early there.

[gdog]

NAAS Buy $2.77 Sell $3.79 now $5.20 sick

[gdog]

ok I just meant I hoped you weren't in higher because of the dip I'm still watching g/l

[Boxsterfan]

This is Bottom Swing Plays Chat, right? Recent Bottom Swing on SLS was a brief dip to $0.81 (for about 2 minutes) a few weeks back. Didn't get that.

I'm buying SLS now because

1. Phase 3 Regal Trial data imminent for drug GPS.
2. In the last 30 days, their drug SLS009 has received two (2) Priority Review Vouchers for Rare Pediatic Disease Designation (RPDD) because the drug has a 99%+ overall response rate in patients.
3. Commercial team left in March 2024. Company is looking to be bought out and actively seeking such. Abbvie, Merck, Novartis are my guesses for interested parties.

[gdog]

I hope your in alot lower :+)

[Boxsterfan]

I'm 200,000 shares long right now.